Back to search

Elite Pharma (Surrey) Limited

06077954

active
Private Limited Company
Companies House
Health Score
88 / 100

Healthy

30/30
Filing
20/30
Financial
38/40
Risk
  • 1 outstanding charge (-2)

Details

UNIT 2, MOLESEY BUSINESS CENTRE, WEST MOLESEY, KT8 2QZ
Incorporated 01/02/2007

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

46460
Wholesale of pharmaceutical goods

Officers

Mr Ashokkumar Dahyabhai Patel

secretary · Since 01/02/2007

COMPANY SECRETARY

BRITISH · UNITED KINGDOM · Age 70

Also on 14 other boards

Mr Ashokkumar Dahyabhai Patel

director · Since 01/02/2007

DIRECTOR SECRETARY

BRITISH · UNITED KINGDOM · Age 70

Also on 14 other boards

Mr Ramesh Vasudev Patel

director · Since 01/02/2007

PHARMACIST

BRITISH · UNITED KINGDOM · Age 79

Also on 5 other boards

Mr Kiritkumar Meghji Shah

director · Since 12/03/2007

PHARMACIST

BRITISH · UNITED KINGDOM · Age 70

Also on 4 other boards

Persons with Significant Control

Mr Kiritkumar Meghji Shah

50–75% shares
50–75% votes
Appoint directors

British · United Kingdom · Age 70

Unit 2, Molesey Business Centre, Central Avenue, West Molesey, KT8 2QZ

Notified 06/04/2016

Former PSCs

Mr Ramesh Vasudev Patel

Ceased 13/05/2019

Mr Ashokkumar Dahyabhai Patel

Ceased 13/05/2019

Charges1 outstanding

Charge
outstanding

LLOYDS BANK COMMERCIAL FINANCE LTD

Created 08/03/2017Registered 13/03/2017
Charge
satisfied

HSBC BANK PLC

Created 19/04/2016Registered 21/04/2016Satisfied 13/02/2017
Charge
satisfied

HSBC INVOICE FINANCE (UK) LTD

Created 16/03/2016Registered 16/03/2016Satisfied 12/04/2021
Charge
satisfied

HSBC INVOICE FINANCE (UK) LTD

Created 16/03/2016Registered 16/03/2016Satisfied 12/04/2021
Charge
satisfied

HSBC BANK PLC

Created 29/02/2016Registered 01/03/2016Satisfied 13/02/2017
Charge
satisfied

BARCLAYS BANK PLC

Created 11/11/2014Registered 13/11/2014Satisfied 26/01/2017
charge
satisfied

BARCLAYS BANK PLC

Created 30/08/2007Registered 12/09/2007Satisfied 26/08/2010

CompanyRankvs 910+ SIC 46460 peers
51

Financial strength67th percentile among SIC peers · 17/25
Employees77th percentile among SIC peers · 12/15
LiquidityCurrent ratio -2.16× · 2/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Rayburn Trading Company Limited
90
2Servier Laboratories Limited
90
3P & A J Cattee (Wholesale) Ltd.
90
4Hameln Pharma Ltd
90
5Day Lewis Medical Limited
90
6Kinetic Enterprises Limited
90
7Morningside Pharmaceuticals Limited
90
8A1 Pharmaceuticals Public Limited Company
90
9Greiner Bio-One Limited
90
10Trafalgar Scientific Limited
90
910Elite Pharma (Surrey) Limited
59
How is this score calculated?
Financial strength17/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/08/2025

Net Worth

£23k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£23k

Working capital

Current Assets

£16k

Current Liabilities

-£7k

3avg. employees

People Costs(2022)

Wages & salaries£305k
NI contributions£25k

Balance Sheet

Assets less current liabilities£23k
Prepared with Sage Accounts Production 24.0 - FRS102_2024

EstimatesDerived

YearCurrent RatioImplied Profit
20252.16-£719
20242.18-£17k
20231.36-£43k
20222.55—

Derived from filed accounts. Not audited figures.